Publication | Closed Access

IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme

Neuro-oncologyOncologySomatic VariantGliomaTumor HeterogeneityPrimary Glioblastoma MultiformeIdh1 MutationsMedicinePathologyCancer GenomicsHigh-grade GliomasMolecular DiagnosticsRadiation OncologyMgmt HypermethylationTumor BiologyHealth Sciences